Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents

HM Zhou, JG Zhang, X Zhang, Q Li - Signal transduction and targeted …, 2021 - nature.com
Cancer stem cells (CSCs) show a self-renewal capacity and differentiation potential that
contribute to tumor progression and therapy resistance. However, the underlying processes …

Alteration of the antitumor immune response by cancer-associated fibroblasts

L Ziani, S Chouaib, J Thiery - Frontiers in immunology, 2018 - frontiersin.org
Among cells present in the tumor microenvironment, activated fibroblasts termed cancer-
associated fibroblasts (CAFs), play a critical role in the complex process of tumor-stroma …

Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy

Z Li, R Pai, S Gupta, J Currenti, W Guo… - Nature Cancer, 2024 - nature.com
Onco-fetal reprogramming of the tumor ecosystem induces fetal developmental signatures in
the tumor microenvironment, leading to immunosuppressive features. Here, we employed …

Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment

L Bu, H Baba, N Yoshida, K Miyake, T Yasuda… - Oncogene, 2019 - nature.com
Increasing lines of evidence show that the malignant behavior of cancer is not exclusively
attributable to cancer cells but also radically influenced by cancerous stroma activity and …

A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells

DA Moraes, TT Sibov, LF Pavon, PQ Alvim… - Stem cell research & …, 2016 - Springer
Abstract Background Mesenchymal stromal cells (MSCs) are multipotent progenitor cells
used in several cell therapies. MSCs are characterized by the expression of CD73, CD90 …

The reactive stroma microenvironment and prostate cancer progression

DA Barron, DR Rowley - Endocrine-related cancer, 2012 - erc.bioscientifica.com
Reactive stroma initiates during early prostate cancer development and coevolves with
prostate cancer progression. Previous studies have defined the key markers of reactive …

Regulation of the anti-tumour immune response by cancer-associated fibroblasts

J Harper, RCA Sainson - Seminars in cancer biology, 2014 - Elsevier
The microenvironment of established tumours is often immunosuppressed, and this allows
tumours to grow and disseminate without being eliminated by the patient's immune system …

What is new in cancer-associated fibroblast biomarkers?

Z Zhao, T Li, Y Yuan, Y Zhu - Cell Communication and Signaling, 2023 - Springer
The tumor microenvironment is one of the important drivers of tumor development. Cancer-
associated fibroblasts (CAFs) are a major component of the tumor stroma and actively …

Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state

M Shimoda, S Principe, HW Jackson, V Luga… - Nature cell …, 2014 - nature.com
Cancer-associated fibroblasts (CAFs) drive tumour progression, but the emergence of this
cell state is poorly understood. A broad spectrum of metalloproteinases, controlled by the …

THY1-mediated mechanisms converge to drive YAP activation in skin homeostasis and repair

E Sedov, E Koren, S Chopra, R Ankawa… - Nature Cell …, 2022 - nature.com
Anchored cells of the basal epidermis constantly undergo proliferation in an overcrowded
environment. An important regulator of epidermal proliferation is YAP, which can be …